Goldman Sachs’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-131,984
| Closed | -$1.98M | – | 4743 |
|
|
2016
Q2 | $1.98M | Sell |
131,984
-35,994
| -21% | -$539K | ﹤0.01% | 2620 |
|
|
2016
Q1 | $2.04M | Buy |
167,978
+51,622
| +44% | +$628K | ﹤0.01% | 2504 |
|
|
2015
Q4 | $1.85M | Sell |
116,356
-25,977
| -18% | -$413K | ﹤0.01% | 2562 |
|
|
2015
Q3 | $2.18M | Sell |
142,333
-104,264
| -42% | -$1.6M | ﹤0.01% | 2490 |
|
|
2015
Q2 | $6M | Buy |
246,597
+51,539
| +26% | +$1.25M | ﹤0.01% | 1978 |
|
|
2015
Q1 | $4.54M | Buy |
195,058
+73,226
| +60% | +$1.7M | ﹤0.01% | 2080 |
|
|
2014
Q4 | $3.06M | Buy |
121,832
+114,246
| +1,506% | +$2.87M | ﹤0.01% | 2261 |
|
|
2014
Q3 | $236K | Sell |
7,586
-179,849
| -96% | -$5.6M | ﹤0.01% | 3840 |
|
|
2014
Q2 | $4.85M | Sell |
187,435
-317,904
| -63% | -$8.22M | ﹤0.01% | 2026 |
|
|
2014
Q1 | $11.8M | Sell |
505,339
-50,573
| -9% | -$1.18M | ﹤0.01% | 1505 |
|
|
2013
Q4 | $14.1M | Buy |
555,912
+24,864
| +5% | +$631K | ﹤0.01% | 1385 |
|
|
2013
Q3 | $10.8M | Buy |
531,048
+109,768
| +26% | +$2.24M | ﹤0.01% | 1440 |
|
|
2013
Q2 | $8.84M | Buy |
+421,280
| New | +$8.84M | ﹤0.01% | 1440 |
|